1st December 2025 Sarah, Angela and Simon attended the LEGACY IIII Network Launch in Liverpool (and online). LEGACY IIII stands for: Lymph nodE single-cell Genomics AnCestrY immunity, infection, inflammation and immunisation. This network, co-led by Kat Pollock, Lucy Jones and John Isaacs and funded by Medical Research Council (MRC), aims to connect 10 specialist centres across the UK to transform lymph-node human immunology research by generating transformative, open-science resources to accelerate discoveries across infection, vaccination, inflammation and immune-mediated disease.
Major investment puts UK universities at the forefront of groundbreaking lymph node research — Oxford Vaccine Group